TLPH
Acelrx Pharmaceuticals Inc

15,402
Mkt Cap
$62.46M
Volume
193,906.00
52W High
$1.45
52W Low
$0.38
PE Ratio
-3.36
TLPH Fundamentals
Price
$1.34
Prev Close
$1.24
Open
$1.23
50D MA
$0.9541
Beta
0.74
Avg. Volume
3.91M
EPS (Annual)
-$0.5031
P/B
4.15
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Talphera Announces the Appointment of Joe Todisco to Board of Directors
Talphera Announces the Appointment of Joe Todisco to Board of Directors Talphera Announces the Appointment of Joe Todisco to Board of Directors PR Newswire SAN MATEO, Calif., Oct. 21, 2025 SAN MATEO...
PR Newswire·11d ago
News Placeholder
More News
News Placeholder
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study Talphera Announces Agreement with the FDA for Prior Approval...
PR Newswire·10mo ago
News Placeholder
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent...
PR Newswire·11mo ago
News Placeholder
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...
PR Newswire·1y ago
News Placeholder
An Overview of Talphera's Earnings
read more...
Benzinga·1y ago
News Placeholder
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 Talphera to Host Third Quarter 2024 Financial Results and Corporate Update...
PR Newswire·1y ago
News Placeholder
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit PR Newswire SAN MATEO...
PR Newswire·1y ago
News Placeholder
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire SAN MATEO...
PR Newswire·1y ago
News Placeholder
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit Talphera Announces First Patient Enrolled in the...
PR Newswire·1y ago
News Placeholder
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...
PR Newswire·1y ago

Latest TLPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.